The business model of cutting-edge medicine.
www.bloomberg.com
#D.A #Wallach #Explains #Biotech
D.A. Wallach Explains Why Biotech VC Is So Different
Related Posts
Buyer of Goldman Sachs’ Russian Unit Steps Into the Middle East
David Amaryan, the former hedge fund manager who bought Goldman Sachs Group Inc.’s business in Russia, is expanding into the…
HK Tycoon Cheng Seeks Sale of Some Rosewood Hotels
Hong Kong tycoon Henry Cheng is seeking buyers for properties in the family’s luxury Rosewood Hotel Group as the billionaire…
Apollo’s Jim Zelter Looks Ahead to 2026
Apollo Global Management President Jim Zelter looks at some of the expectations for the year ahead while highlighting this year’s…